Patent ID: 11857713
Assignee: BAXTER INTERNATIONAL INC.
Field: Medical technology (Instruments)
Classification: CPC A  G | IPC A  G

Claim 0:
1. An automated peritoneal dialysis apparatus comprising:
at least one pump;
a first solution having a first formulation including a lower dextrose concentration placed in fluid communication with the at least one pump, the first solution stored in a first container, a first unique identifier associated with the first container, the first unique identifier indicative of the first formulation;
a first valve fluidly coupled to the first container;
a second solution having a second formulation including a higher dextrose concentration placed in fluid communication with the at least one pump, the second solution stored in a second container, a second unique identifier associated with the second container, the second unique identifier indicative of the second formulation;
a second valve fluidly coupled to the second container;
a memory device configured to simultaneously store a first standard ultrafiltration (“UF”) therapy prescription with a longer duration and a lower dextrose concentration and a second standard UF therapy prescription with a shorter duration and a higher dextrose concentration; and
a logic implementer programmed to:
receive a patient weight value,
determine a weight difference between the patient weight value and at least one prior patient weight value,
when the weight difference is below a threshold, cause the first standard UF therapy prescription and the second standard UF therapy prescription to be displayed as possible options for selection,
when the weight difference is above the threshold, prevent the second standard UF therapy prescription from being displayed as a possible option for selection,
receive via a user interface a selection of the first standard UF therapy prescription or the second standard UF therapy prescription, and
operate the at least one pump and:
(i) open the first valve when the first formulation indicated by the first unique identifier is specified by the first standard UF therapy prescription and the first standard UF therapy prescription is selected via the user interface, and
(ii) open the second valve when the second formulation indicated by the second unique identifier is specified by the second standard UF therapy prescription and the second standard UF therapy prescription is selected via the user interface.